China Peptide Therapeutics Market (2025-2031) | Share, Industry, Growth, Companies, Forecast, Analysis, Competitive Landscape, Trends, Size & Revenue, Value, Outlook, Segmentation

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 China Country Macro Economic Indicators

3.2 China Peptide Therapeutics Market Revenues & Volume, 2021 & 2031F

3.3 China Peptide Therapeutics Market - Industry Life Cycle

3.4 China Peptide Therapeutics Market - Porter's Five Forces

3.5 China Peptide Therapeutics Market Revenues & Volume Share, By Product Type, 2021 & 2031F

3.6 China Peptide Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 China Peptide Therapeutics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 China Peptide Therapeutics Market Revenues & Volume Share, By Types of Peptide, 2021 & 2031F

3.9 China Peptide Therapeutics Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.10 China Peptide Therapeutics Market Revenues & Volume Share, By Manufacturing Type, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic diseases in China leading to higher demand for peptide therapeutics

4.2.2 Growing investments in research and development of peptide-based drugs in China

4.2.3 Favorable government initiatives and policies supporting the development of peptide therapeutics market in China

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for the approval of peptide drugs in China

4.3.2 High costs associated with peptide drug development and manufacturing

4.3.3 Limited awareness and adoption of peptide therapeutics among healthcare professionals and patients in China

6.1 China Peptide Therapeutics Market, By Product Type

6.1.1 Overview and Analysis

6.1.2 China Peptide Therapeutics Market Revenues & Volume, By Product Type, 2021- 2031F

6.1.3 China Peptide Therapeutics Market Revenues & Volume, By Innovative, 2021- 2031F

6.1.4 China Peptide Therapeutics Market Revenues & Volume, By Generic, 2021- 2031F

6.2 China Peptide Therapeutics Market, By Application

6.2.1 Overview and Analysis

6.2.2 China Peptide Therapeutics Market Revenues & Volume, By Metabolic, 2021- 2031F

6.2.3 China Peptide Therapeutics Market Revenues & Volume, By Oncology, 2021- 2031F

6.2.4 China Peptide Therapeutics Market Revenues & Volume, By Gastrointestinal, 2021- 2031F

6.2.5 China Peptide Therapeutics Market Revenues & Volume, By Cardiovascular, 2021- 2031F

6.2.6 China Peptide Therapeutics Market Revenues & Volume, By Neurological, 2021- 2031F

6.2.7 China Peptide Therapeutics Market Revenues & Volume, By Others, 2021- 2031F

6.3 China Peptide Therapeutics Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 China Peptide Therapeutics Market Revenues & Volume, By Parenteral, 2021- 2031F

6.3.3 China Peptide Therapeutics Market Revenues & Volume, By Oral, 2021- 2031F

6.3.4 China Peptide Therapeutics Market Revenues & Volume, By Others, 2021- 2031F

6.4 China Peptide Therapeutics Market, By Types of Peptide

6.4.1 Overview and Analysis

6.4.2 China Peptide Therapeutics Market Revenues & Volume, By Native Peptides, 2021- 2031F

6.4.3 China Peptide Therapeutics Market Revenues & Volume, By Analog Peptides, 2021- 2031F

6.4.4 China Peptide Therapeutics Market Revenues & Volume, By Heterologous Peptides, 2021- 2031F

6.5 China Peptide Therapeutics Market, By Technology

6.5.1 Overview and Analysis

6.5.2 China Peptide Therapeutics Market Revenues & Volume, By Liquid Phase, 2021- 2031F

6.5.3 China Peptide Therapeutics Market Revenues & Volume, By Solid phase, 2021- 2031F

6.5.4 China Peptide Therapeutics Market Revenues & Volume, By Hybrid, 2021- 2031F

6.6 China Peptide Therapeutics Market, By Manufacturing Type

6.6.1 Overview and Analysis

6.6.2 China Peptide Therapeutics Market Revenues & Volume, By In-house, 2021- 2031F

6.6.3 China Peptide Therapeutics Market Revenues & Volume, By CMO, 2021- 2031F

7.1 China Peptide Therapeutics Market Export to Major Countries

7.2 China Peptide Therapeutics Market Imports from Major Countries

8.1 Number of clinical trials conducted for peptide therapeutics in China

8.2 Adoption rate of peptide drugs by healthcare providers in China

8.3 Investment trends in the Chinese peptide therapeutics market

9.1 China Peptide Therapeutics Market Opportunity Assessment, By Product Type, 2021 & 2031F

9.2 China Peptide Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 China Peptide Therapeutics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 China Peptide Therapeutics Market Opportunity Assessment, By Types of Peptide, 2021 & 2031F

9.5 China Peptide Therapeutics Market Opportunity Assessment, By Technology, 2021 & 2031F

9.6 China Peptide Therapeutics Market Opportunity Assessment, By Manufacturing Type, 2021 & 2031F

10.1 China Peptide Therapeutics Market Revenue Share, By Companies, 2024

10.2 China Peptide Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters